Similar Posts
My powerpoint presentation to NVIC conference
The presentation discussed the legal framework for scientific misconduct, other questionable practices in science that are not legally prohibited, and how such practices were employed to create a body of literature that falsely proclaims anthrax vaccine’s safety. Also discussed was the role of anthrax vaccine in bioterrorism, its history since 1970, and the new laws…
My interview with Kate Dalley, November 12, 2021
https://soundcloud.com/katedalleyradio/111221-dr-meryl-nass-speaks-out-liability-informed-consent-must-listen
Kristian Andersen, still young and brash, thinks doubletalk will save him and his brilliant career
He is digging in his heels. Maybe he thinks tenure will save him. Will the juicy grants dry up? Fauci did reward him with one. He hasn’t learned that the best think to do when the jig is up is to shut up. He is doing a Fauci, wrapping himself in the Science. https://www.nytimes.com/2021/06/14/science/covid-lab-leak-fauci-kristian-andersen.html My…
USG buys too much vaccine. Governments Sign Secret Vaccine Deals: Here’s What They Hide/ NYT
Check out this NY Times article published today. The US government is buying much more vaccine than is needed for every American. But it also has signed contracts restricting the overseas sale of some of its purchases. So if it can’t be sold, why is the government committed to buying so much? Is the plan…
Chinese trial of H1N1 vaccines/NEJM
A 2200 subject trial of Chinese H1N1 vaccines (developed from the same CDC virus as vaccines developed by western manufacturers) was published in the NEJM. Four strengths of antigen were used in 4 age groups, with and without an aluminum phosphate (not a novel) adjuvant. Of interest: 15 mcg of antigen was sufficient. (This is…
As pressure for coronavirus vaccine mounts, scientists debate risks of accelerated testing/ Reuters
https://www.reuters.com/article/us-health-coronavirus-vaccines-insight/as-pressure-for-coronavirus-vaccine-mounts-scientists-debate-risks-of-accelerated-testing-idUSKBN20Y1GZ? CHICAGO (Reuters) – Drugmakers are working as quickly as possible to develop a vaccine to combat the rapidly spreading coronavirus that has infected more than 100,000 people worldwide. Behind the scenes, scientists and medical experts are concerned that rushing a vaccine could end up worsening the infection in some…